Related Experiment Video
Updated: Jul 5, 2026
10:37
Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
Rapid identification of CD4+ T-cell epitopes using yeast displaying pathogen-derived peptide library
Fei Wen1, Olga Esteban, Huimin Zhao
1Department of Chemical and Biomolecular Engineering, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States.
Journal of Immunological Methods
|May 2, 2008
Summary
We developed a rapid, high-throughput method to identify CD4+ T-cell epitopes using yeast display. This technique accurately pinpoints antigenic peptides for improved immune response studies.
Area of Science:
- Immunology
- Molecular Biology
- Biotechnology
Background:
- CD4+ T-cell epitope identification is crucial for understanding immune responses to various diseases.
- Current methods can be time-consuming and lack high-throughput capabilities.
Purpose of the Study:
- To develop a facile, accurate, and high-throughput method for CD4+ T-cell epitope identification.
- To enable rapid pinpointing of antigenic peptides from complex pathogen-derived libraries.
Main Methods:
- Utilized a yeast display system with a peptide library encoding 10-20 amino acid fragments from antigens.
- Fused peptide fragments to a single-chain MHC class II molecule in a yeast display vector.
- Analyzed yeast library using Fluorescence-Activated Cell Sorting (FACS) for high-affinity peptide binders, followed by T-cell activation screening.
Main Results:
- Successfully identified the HA(306-322) epitope from the haemagglutinin protein.
- Demonstrated the method's efficacy by analyzing the entire influenza virus X31/A/Aichi/68 genome.
- Achieved rapid and accurate identification of antigenic peptides.
Conclusions:
- The developed yeast display method offers a powerful tool for high-throughput CD4+ T-cell epitope discovery.
- This approach significantly accelerates the identification of key antigenic peptides for immunological research and therapeutic development.
